Health Canada inspection
Ipsen Biopharmaceuticals Canada Inc: Health Canada inspection of Mar 26, 2024
Health Canada · GVP · rating C
Key facts
| Establishment | Ipsen Biopharmaceuticals Canada Inc |
|---|---|
| City | Mississauga |
| Province | Ontario |
| Country | Canada |
| Program | GVP |
| Start date | Mar 18, 2024 |
| End date | Mar 26, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 102222 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: